Clinical Trials Drug Trials FDA Approval RNA 
Drug Discovery World
MARCH 7, 2023
She founded Neuroute in 2019, with the aim of empowering patients from diverse backgrounds to participate in drug trials. Prior to Twist Bioscience, she worked at Agilent Technologies and at the University of Houston developing DNA and RNA parallel synthesis processes on solid support.
Drug Discovery World
JANUARY 17, 2024
Brett Swansiger, Chief Commercial Officer at ANGLE discusses the importance of liquid biopsies in precision medicine trials for cancer. Furthermore, oncology clinical trials are frequently challenged by low enrolment rates, failure to achieve primary endpoints, study design complexity and limited funding 5.
Expert insights. Personalized for you.
98 
Let's personalize your content